BlackRock’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95.9M Buy
6,843,733
+92,822
+1% +$1.25M ﹤0.01% 2137
2025
Q4
$75.8M Sell
6,750,911
-82,860
-1% -$948K ﹤0.01% 2270
2025
Q3
$79M Buy
6,833,771
+4,457
+0.1% +$52.2K ﹤0.01% 2241
2025
Q2
$83.6M Sell
6,829,314
-67,654
-1% -$851K ﹤0.01% 2163
2025
Q1
$98.8M Sell
6,896,968
-254,859
-4% -$3.98M ﹤0.01% 1997
2024
Q4
$114M Buy
7,151,827
+104,639
+1% +$2.07M ﹤0.01% 2004
2024
Q3
$169M Buy
7,047,188
+35,969
+0.5% +$822K ﹤0.01% 1761
2024
Q2
$140M Sell
7,011,219
-248,055
-3% -$4.83M ﹤0.01% 1836
2024
Q1
$145M Sell
7,259,274
-202,069
-3% -$3.91M ﹤0.01% 1846
2023
Q4
$167M Buy
7,461,343
+327,866
+5% +$6.77M ﹤0.01% 1761
2023
Q3
$144M Sell
7,133,477
-164,627
-2% -$3.73M ﹤0.01% 1766
2023
Q2
$187M Sell
7,298,104
-160,472
-2% -$4.23M 0.01% 1629
2023
Q1
$222M Sell
7,458,576
-112,472
-1% -$3.27M 0.01% 1466
2022
Q4
$205M Buy
7,571,048
+189,466
+3% +$4.63M 0.01% 1514
2022
Q3
$161M Sell
7,381,582
-229,542
-3% -$6M 0.01% 1637
2022
Q2
$208M Sell
7,611,124
-3,012
-0% -$86.5K 0.01% 1498
2022
Q1
$255M Buy
7,614,136
+688
+0% +$22.2K 0.01% 1487
2021
Q4
$264M Buy
7,613,448
+319,548
+4% +$10.3M 0.01% 1530
2021
Q3
$228M Sell
7,293,900
-78,594
-1% -$2.67M 0.01% 1619
2021
Q2
$268M Buy
7,372,494
+1,761,426
+31% +$72.8M 0.01% 1552
2021
Q1
$245M Buy
5,611,068
+287,727
+5% +$13.5M 0.01% 1591
2020
Q4
$244M Buy
5,323,341
+177,432
+3% +$7.39M 0.01% 1466
2020
Q3
$171M Sell
5,145,909
-201,136
-4% -$6.43M 0.01% 1504
2020
Q2
$157M Sell
5,347,045
-73,430
-1% -$2.13M 0.01% 1528
2020
Q1
$146M Sell
5,420,475
-131,283
-2% -$3.92M 0.01% 1385
2019
Q4
$187M Sell
5,551,758
-28,427
-0.5% -$1.03M 0.01% 1555
2019
Q3
$209M Buy
5,580,185
+114,453
+2% +$4.37M 0.01% 1372
2019
Q2
$238M Buy
5,465,732
+23,000
+0.4% +$984K 0.01% 1294
2019
Q1
$232M Buy
5,442,732
+1,436
+0% +$64.3K 0.01% 1296
2018
Q4
$244M Buy
5,441,296
+177,524
+3% +$9.3M 0.01% 1168
2018
Q3
$361M Buy
5,263,772
+82,497
+2% +$5.31M 0.02% 1023
2018
Q2
$297M Buy
5,181,275
+186,145
+4% +$9.84M 0.01% 1120
2018
Q1
$230M Buy
4,995,130
+52,167
+1% +$2.48M 0.01% 1252
2017
Q4
$228M Sell
4,942,963
-293,692
-6% -$13.5M 0.01% 1271
2017
Q3
$236M Sell
5,236,655
-61,947
-1% -$2.64M 0.01% 1212
2017
Q2
$208M Sell
5,298,602
-640,750
-11% -$24.2M 0.01% 1275
2017
Q1
$226M Buy
5,939,352
+5,847,442
+6,362% +$228M 0.01% 1177
2016
Q4
$3.4M Sell
91,910
-5,666
-6% -$203K ﹤0.01% 1042
2016
Q3
$3.38M Buy
97,576
+11,904
+14% +$417K ﹤0.01% 1025
2016
Q2
$2.79M Sell
85,672
-852
-1% -$26.1K ﹤0.01% 1029
2016
Q1
$2.48M Sell
86,524
-6,278
-7% -$167K ﹤0.01% 1043
2015
Q4
$3.1M Buy
92,802
+64,230
+225% +$2M ﹤0.01% 948
2015
Q3
$812K Sell
28,572
-115,828
-80% -$4.04M ﹤0.01% 1361
2015
Q2
$5.85M Sell
144,400
-50,568
-26% -$2.27M 0.01% 798
2015
Q1
$9.59M Sell
194,968
-11,052
-5% -$512K 0.01% 693
2014
Q4
$9.37M Buy
+206,020
New +$8.09M 0.01% 696

Other funds holding AVNS